ERBB3 and ERBB2 levels are frequently associated, especially in human breast cancers, where ERBB3/ERBB2 heterodimers function as an oncogenic driver for breast tumor cell proliferation [9] (reviewed in [1,5]). This evidence concerns the gene ERBB2 and breast neoplasm.